How much funding has Annovation Biopharma raised?

Annovation Biopharma has raised $8.0M in total funding, most recently a Venture Round.

Who are Annovation Biopharma's investors?

Annovation Biopharma's investors include Atlas Venture, Partners Innovation Fund.

When was Annovation Biopharma founded?

Annovation Biopharma was founded in 2009.

Where is Annovation Biopharma headquartered?

Annovation Biopharma is headquartered in Cambridge, Massachusetts.

What industry is Annovation Biopharma in?

Annovation Biopharma operates in Biotech, Healthcare.

How many employees does Annovation Biopharma have?

Annovation Biopharma has 1-10 employees.

Annovation Biopharma

Acquired

Next-generation anesthetic agents for safer surgical care

Cambridge · Founded 2009 · $8.0M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 1–10
Founded: 2009
Business Model: B2B

Total Funding: $8.0M
Last Round: $8.0M Venture Round
Rounds: 1

About

Annovation Biopharma, Inc. was a pharmaceutical company developing next-generation anesthetic agents in the fields of anesthesia, sedation, and sleep. Founded in 2009 and based in Cambridge, Massachusetts, the company advanced an MGH-derived lead compound, ABP-700, designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. Annovation raised an $8 million Series A in 2012 led by Atlas Venture, with participation from Partners Innovation Fund and The Medicines Company. The company was subsequently acquired by The Medicines Company in February 2015 for $61.6 million in cash and milestones.

Summary

Annovation Biopharma is a Biotech company based in Cambridge, founded in 2009. It has raised $8.0M in total across 1 round. Investors include Atlas Venture and Partners Innovation Fund.